CSPC Pharmaceutical Group Limited Net Asset Quality Index
CSPC Pharmaceutical Group Limited net asset quality index. CSPC Pharmaceutical Group Limited (CVG) has a Net Asset Quality Index of 74.0% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €46.70 Billion minus total liabilities of €12.15 Billion yields net assets of €34.55 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See net assets of CSPC Pharmaceutical Group Limited for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of CSPC Pharmaceutical Group Limited (2013–2025)
Net asset quality index of CSPC Pharmaceutical Group Limited from 2013 to 2025. This chart shows how CSPC Pharmaceutical Group Limited's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of December 2025, the index stands at 74.0%, representing net assets of €34.55 Billion against total assets of €46.70 Billion EUR. Check CSPC Pharmaceutical Group Limited (CVG) strategic investment index to assess the company's strategic physical and investment asset allocation.
CSPC Pharmaceutical Group Limited Net Asset Quality Index by Year (2013–2025)
CSPC Pharmaceutical Group Limited net asset quality index by year from 2013 to 2025. The table below presents the year-by-year Net Asset Quality Index for CSPC Pharmaceutical Group Limited from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CSPC Pharmaceutical Group Limited stock valuation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 74.0% | €34.55 Billion | €46.70 Billion | €12.15 Billion | ▼ -2.3 pp |
| 2024 | 76.3% | €33.87 Billion | €44.39 Billion | €10.52 Billion | ▲ +0.6 pp |
| 2023 | 75.7% | €35.02 Billion | €46.28 Billion | €11.26 Billion | ▼ -0.1 pp |
| 2022 | 75.8% | €31.64 Billion | €41.77 Billion | €10.13 Billion | ▼ -1.5 pp |
| 2021 | 77.2% | €26.83 Billion | €34.74 Billion | €7.91 Billion | ▲ +0.4 pp |
| 2020 | 76.8% | €23.10 Billion | €30.07 Billion | €6.97 Billion | ▲ +2.7 pp |
| 2019 | 74.2% | €19.52 Billion | €26.32 Billion | €6.80 Billion | ▲ +7.3 pp |
| 2018 | 66.9% | €15.50 Billion | €23.17 Billion | €7.67 Billion | ▼ -4.6 pp |
| 2017 | 71.5% | €12.87 Billion | €18.00 Billion | €5.13 Billion | ▲ +2.5 pp |
| 2016 | 69.0% | €9.13 Billion | €13.22 Billion | €4.09 Billion | ▲ +4.0 pp |
| 2015 | 65.1% | €8.81 Billion | €13.54 Billion | €4.73 Billion | ▼ -0.1 pp |
| 2014 | 65.2% | €8.15 Billion | €12.50 Billion | €4.35 Billion | ▲ +2.9 pp |
| 2013 | 62.3% | €7.60 Billion | €12.20 Billion | €4.60 Billion | — |